Because God Said (Part 1)

In the surgery study, one low titer persistent inhibitor and one transient false-positive inhibitor were reported. Alora was shown to be statistically significantly superior to placebo at Weeks 4 and 12 for relief of both the frequency (see Table 5) and severity of vasomotor symptoms. Selumetinib: (Major) Avoid coadministration of selumetinib and cyclosporine due to […]